Valuation : Yuhan Corporation

Market Cap 6,073B 4.49B 3.89B 3.64B 3.34B 6.24B 425B 6.26B 43.18B 16.77B 218B 16.88B 16.51B 707B P/E 2026 *
40.9x
P/E 2027 * 29.6x
Enterprise Value 5.99B 4.43M 3.84M 3.59M 3.3M 6.16M 419M 6.18M 42.61M 16.55M 215M 16.65M 16.29M 697M EV / Sales 2026 *
2.56x
EV / Sales 2027 * 2.31x
Free-Float
61.43%
Yield 2026 *
0.7%
Yield 2027 * 0.7%
1 week-4.12%
Current month-2.75%
1 month+8.82%
3 months+1.62%
6 months-11.90%
Current year-27.58%
1 week 80,900
Extreme 80900
84,700
1 month 75,000
Extreme 75000
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.12%-31.08%+21.23% 4.51B
-1.32%+1.33%+78.86%+36.86% 371B
-1.45%-3.14%+25.21%-19.54% 68.64B
-0.51%+4.59%+50.12%+157.33% 12.51B
-1.09%-9.76%-8.91%-9.69% 8.06B
+0.23%-1.59%-19.07%+5.74% 5.04B
-0.35%-3.11%-31.69%+0.12% 3.07B
-1.00%-0.46%-4.18%+33.98% 2.53B
-0.50%-3.98%-23.45%-18.72% 2B
-2.42%-2.22%+227.08%+1,178.99% 1.67B
Average -0.84%-1.84%+26.29%+138.63% 47.89B
Weighted average by Cap. -1.28%+0.86%+65.82%+34.17%

Financials

2026 *2027 *
Net sales 2,340B 1.73B 1.5B 1.4B 1.29B 2.41B 164B 2.41B 16.64B 6.46B 83.87B 6.5B 6.36B 272B 2,556B 1.89B 1.64B 1.53B 1.41B 2.63B 179B 2.63B 18.17B 7.06B 91.59B 7.1B 6.95B 297B
Net income 154B 114M 98.38M 92.08M 84.55M 158M 10.75B 158M 1.09B 424M 5.51B 427M 418M 17.89B 206B 152M 132M 123M 113M 212M 14.4B 212M 1.46B 569M 7.38B 572M 560M 23.97B
Net Debt -80.13B -59.3M -51.28M -48M -44.07M -82.38M -5.6B -82.62M -570M -221M -2.87B -223M -218M -9.33B -162B -120M -104M -96.93M -89M -166M -11.32B -167M -1.15B -447M -5.8B -450M -440M -18.83B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-09-04 ₩81,400.00 0.00% 108,985
26-09-03 ₩81,400.00 +0.12% 256,221
26-09-02 ₩81,300.00 -1.69% 188,082
26-09-01 ₩82,700.00 -1.19% 136,338
26-08-31 ₩83,700.00 -1.41% 640,942
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
81,400.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+47.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock